{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:58:32Z","timestamp":1790744312671,"version":"4.1.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy resulting from deposition of misfolded immunoglobulin light chains (AL-CA) or transthyretin (ATTR-CA) proteins in the myocardium. Survival varies between the different subtypes of amyloidosis and degree of cardiac involvement, but accurate diagnosis is essential to ensure initiation of therapeutic interventions that may slow or potentially prevent morbidity and mortality in these patients. As there are now effective treatment options for CA, identifying underlying disease pathogenesis is crucial and can be guided by multimodality imaging techniques such as echocardiography, magnetic resonance imaging, and nuclear scanning modalities. However, as use of cardiac imaging is becoming more widespread, understanding optimal applications and potential shortcomings is increasingly important. Additionally, certain imaging modalities can provide prognostic information and may affect treatment planning. In patients whom imaging remains non-diagnostic, tissue biopsy, specifically endomyocardial biopsy, continues to play an essential role and can facilitate accurate and timely diagnosis such that appropriate treatment can be started. In this review, we examine the multimodality imaging approach to the diagnosis of CA with particular emphasis on the prognostic utility and limitations of each imaging modality. We also discuss how imaging can guide the decision to pursue tissue biopsy for timely diagnosis of CA.<\/jats:p>","DOI":"10.3389\/fcvm.2022.787618","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T03:28:02Z","timestamp":1648524482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis"],"prefix":"10.3389","volume":"9","author":[{"suffix":"III","given":"Paul J.","family":"Scheel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison G.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joban","family":"Vaishnav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"(Light-chain) cardiac amyloidosis: a review of diagnosis and therapy.","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis.","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01028-8","article-title":"Updates in cardiac amyloidosis diagnosis and treatment.","volume":"23","author":"Stern","year":"2021","journal-title":"Curr Oncol Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.mayocp.2018.08.041","article-title":"Incidence of AL amyloidosis in Olmsted county, Minnesota, 1990 through 2015.","volume":"94","author":"Kyle","year":"2019","journal-title":"Mayo Clin Proc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2-macroglobulinandtau: a population-based autopsy study.","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","article-title":"Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14333 African\u2013Americans.","volume":"22","author":"Jacobson","year":"2015","journal-title":"Amyloid."},{"key":"B7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/blood-2018-06-858951","article-title":"Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis.","volume":"133","author":"Lilleness","year":"2019","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/ehjci\/jeaa063","article-title":"Multimodality imaging in cardiac amyloidosis: a primer for cardiologists.","volume":"21","author":"Jurcut","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2147\/VHRM.S295376","article-title":"Diagnostic work-up of cardiac amyloidosis using cardiovascular imaging: current standards and practical algorithms.","volume":"17","author":"Korosoglou","year":"2012","journal-title":"Vasc Health Risk Manag."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/ehjci\/jeu158","article-title":"The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease.","volume":"15","author":"Di Bella","year":"2014","journal-title":"Eur Heart J Cardvasc Imging."},{"key":"B11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.echo.2015.05.002","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the european association of cardiovascular imaging (EACVI) and the American society of echocardiography (ASE).","volume":"28","author":"Marwick","year":"2015","journal-title":"J Am Soc Echocardiogr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths.","volume":"38","author":"Gonzalez-Lopez","year":"2017","journal-title":"Eur Heart J."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-018-1931-5","article-title":"Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.","volume":"12","author":"Yamamoto","year":"2018","journal-title":"J Med Case Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.echo.2007.02.025","article-title":"Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography.","volume":"20","author":"Bellavia","year":"2007","journal-title":"J Am Soc Echocardiogr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","article-title":"Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis.","volume":"107","author":"Koyama","year":"2003","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.amjcard.2020.07.050","article-title":"Natural history and disease progression of early cardiac amyloidosis evaluated by echocardiography.","volume":"133","author":"Itzhaki Ben Zadok","year":"2020","journal-title":"Am J Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.amjcard.2014.07.026","article-title":"Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis.","volume":"114","author":"Cyrille","year":"2014","journal-title":"Am J Cardiol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo parameters for differential diagnosis in cardiac amyloidosis: a head-to-head comparison of deformation and nondeformation parameters.","volume":"10","author":"Pagourelias","year":"2017","journal-title":"Circ Cardiovasc Imaging."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart."},{"key":"B20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cardfail.2016.12.006","article-title":"Baseline characteristics predict the presence of amyloid on endomyocardial biopsy.","volume":"23","author":"Ton","year":"2017","journal-title":"J Card Fail."},{"key":"B21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.amjcard.2008.09.102","article-title":"Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography.","volume":"103","author":"Sun","year":"2009","journal-title":"Am J Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis.","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13449","article-title":"A simple echocardiographic score to rule out cardiac amyloidosis.","volume":"51","author":"Aimo","year":"2020","journal-title":"Eur J Clin Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s00392-020-01698-7","article-title":"Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis.","volume":"110","author":"Binder","year":"2021","journal-title":"Clin Res Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/01.cir.63.1.188","article-title":"M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.","volume":"63","author":"Siqueira-Filho","year":"1981","journal-title":"Circulation."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1540-8175.2010.01238.x","article-title":"A novel two-dimensional echocardiographic finding in cardiac amyloidosis.","volume":"27","author":"Belkin","year":"2010","journal-title":"Echocardiography."},{"key":"B27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9149(87)90948-9","article-title":"Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis.","volume":"59","author":"Falk","year":"1987","journal-title":"Am J Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/oxfordjournals.eurheartj.a060225","article-title":"Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis.","volume":"13","author":"Hamer","year":"1992","journal-title":"Eur Heart J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/0735-1097(89)90254-4","article-title":"Doppler characterization of left ventricular diastolic function in cardiac amyloidosis.","volume":"13","author":"Klein","year":"1989","journal-title":"J Am Coll Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid."},{"key":"B31","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/01.cir.83.3.808","article-title":"Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study.","volume":"83","author":"Klein","year":"1991","journal-title":"Circulation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur Heart J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00392-017-1167-1","article-title":"Predictors of survival stratification in patients with wild-type cardiac amyloidosis.","volume":"107","author":"Siepen","year":"2018","journal-title":"Clin Res Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J."},{"key":"B35","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ehjci\/jes009","article-title":"Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study.","volume":"13","author":"Bellavia","year":"2012","journal-title":"Eur Heart J Cardiovasc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/13506129.2016.1194264","article-title":"Prognostic value of right ventricular systolic function in cardiac amyloidosis.","volume":"23","author":"Bodez","year":"2016","journal-title":"Amyloid."},{"key":"B37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/jcecho.jcecho_112_20","article-title":"Early impairment of right ventricular morphology and function in transthyretin-related cardiac amyloidosis.","volume":"31","author":"Licordari","year":"2021","journal-title":"J Cardiovasc Echogr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/s0002-9149(97)00400-1","article-title":"Right ventricular dilation in primary amyloidosis.","volume":"80","author":"Patel","year":"1997","journal-title":"Am J Cardiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis.","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc Imaging."},{"key":"B40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.echo.2019.03.005","article-title":"Role of right ventricular strain measured by two-dimensional echocardiography in the diagnosis of cardiac amyloidosis.","volume":"32","author":"Mo\u00f1ivas Palomero","year":"2019","journal-title":"J Am Soc Echocardiogr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/ehjci\/jeaa043","article-title":"Phasic left atrial strain analysis to discriminate cardiac amyloidosis in patients with unclear thick heart pathology.","volume":"22","author":"Brand","year":"2021","journal-title":"Eur Heart J Cardiovasc Imging."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1253\/circj.CJ-16-0364","article-title":"Left atrial morphology, size and function in patients with transthyretin cardiac amyloidosis and primary hypertrophic cardiomyopathy; comparative strain imaging study.","volume":"80","author":"de Gregorio","year":"2016","journal-title":"Circ J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10554-020-01948-9","article-title":"Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.","volume":"37","author":"Rausch","year":"2021","journal-title":"Int J Cardiovasc Imaging."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.jcmg.2021.01.016","article-title":"Prognostic utility of echocardiographic atrial and ventricular strain imaging in patients with cardiac amyloidosis.","volume":"14","author":"Huntjens","year":"2021","journal-title":"JACC Cardiovasc Imaging."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-019-1094-z","article-title":"Echocardiographic findings in cardiac amyloidosis: inside two dimensional, Doppler, and strain imaging.","volume":"21","author":"Di Nunzio","year":"2019","journal-title":"Curr Cardiol Rep."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22877-8","article-title":"Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms.","volume":"12","author":"Goto","year":"2021","journal-title":"Nat Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00330-011-2109-3","article-title":"Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.","volume":"21","author":"Wassmuth","year":"2011","journal-title":"Eur Radiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3109\/13506129.2015.1020153","article-title":"Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging.","volume":"22","author":"Kristen","year":"2015","journal-title":"Amyloid."},{"key":"B49","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/s0002-8703(98)70127-9","article-title":"Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy.","volume":"136","author":"Fattori","year":"1998","journal-title":"Am Heart J."},{"key":"B50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis.","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation."},{"key":"B51","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.amjcard.2008.09.105","article-title":"Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis.","volume":"103","author":"Ruberg","year":"2009","journal-title":"Am J Cardiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00380-017-1043-y","article-title":"Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.","volume":"33","author":"Wan","year":"2018","journal-title":"Heart Vessels."},{"key":"B53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis.","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging."},{"key":"B54","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/hrt.2005.061911","article-title":"Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.","volume":"92","author":"Perugini","year":"2005","journal-title":"Heart."},{"key":"B55","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.amjcard.2015.05.021","article-title":"Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrast-enhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function.","volume":"116","author":"Kwong","year":"2015","journal-title":"Am J Cardiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.amjcard.2008.10.039","article-title":"Comparison of magnetic resonance imaging versus doppler echocardiography for the evaluation of left ventricular diastolic function in patients with cardiac amyloidosis.","volume":"103","author":"Rubinshtein","year":"2009","journal-title":"Am J Cardiol."},{"key":"B57","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis.","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B58","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis.","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation."},{"key":"B59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/13506120802193233","article-title":"Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings.","volume":"15","author":"Hosch","year":"2008","journal-title":"Amyloid."},{"key":"B60","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis.","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc Imaging."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis.","volume":"13","author":"Pan","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94650-2","article-title":"CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis.","volume":"11","author":"Korthals","year":"2021","journal-title":"Sci Rep."},{"key":"B64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/13506129.2019.1578742","article-title":"Regional amyloid distribution and impact on mortality in light-chain amyloidosis: a T1 mapping cardiac magnetic resonance study.","volume":"25","author":"Wan","year":"2019","journal-title":"Amyloid."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s10554-018-1410-5","article-title":"3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping.","volume":"34","author":"Avitzur","year":"2018","journal-title":"Int J Cardiovasc Imaging."},{"key":"B66","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41569-020-0334-7","article-title":"Diagnostic imaging of cardiac amyloidosis.","volume":"17","author":"Martinez-Naharro","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3348\/kjr.2020.0579","article-title":"Regional Amyloid burden differences evaluated using quantitative cardiac MRI in patients with cardiac amyloidosis.","volume":"22","author":"Kim","year":"2021","journal-title":"Korean J Radiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/jmri.25718","article-title":"Magnetic resonance imaging of myocardial strain: a review of current approaches.","volume":"46","author":"Chitiboi","year":"2017","journal-title":"J Magn Reson Imaging."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jcmg.2009.08.008","article-title":"Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.","volume":"2","author":"Austin","year":"2009","journal-title":"JACC Cardiovasc Imaging."},{"key":"B70","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jcmg.2017.02.012","article-title":"CMR-verified regression of cardiac AL amyloid after chemotherapy.","volume":"11","author":"Martinez-Naharro","year":"2018","journal-title":"J Am Coll Cardiol Cardiovasc Imaging."},{"key":"B71","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/BF00998166","article-title":"Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis.","volume":"16","author":"Janssen","year":"1990","journal-title":"Eur J Nucl Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","article-title":"Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.","volume":"45","author":"Treglia","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B73","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00259-001-0730-0","article-title":"99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy.","volume":"29","author":"Puille","year":"2002","journal-title":"Eur J Nucl Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis.","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation."},{"key":"B75","first-page":"p. 1","author":"Dorbala","year":"2019","journal-title":"99mTechntium-Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis. ASNC Cardiac Amyloidosis Practice Points"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1016\/j.jacc.2020.04.022","article-title":"Cardiac scintigraphy with technetium-99m-labeled bone-seeking tracers for suspected amyloidosis.","volume":"75","author":"Hanna","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99m Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1007\/s12350-020-02205-1","article-title":"Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: comparison of quantitative and semi\u2013 quantitative approaches.","volume":"27","author":"R\u00e9gis","year":"2020","journal-title":"J Nucl Cardiol."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-020-02396-7","article-title":"Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy.","author":"Soumalainen","year":"2020","journal-title":"J Nucl Cardiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc Imaging."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc."},{"key":"B83","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","article-title":"Usefulness of99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.","volume":"22","author":"Galat","year":"2015","journal-title":"Amyloid."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis.","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis.","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail."},{"key":"B86","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s12350-021-02575-0","article-title":"BRIEF REPORT The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy.","volume":"28","author":"Bianco","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.","volume":"54","author":"Antoni","year":"2012","journal-title":"J Nucl Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12149-019-01372-7","article-title":"Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomography.","volume":"33","author":"Dietemann","year":"2019","journal-title":"Ann Nucl Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography.","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study.","volume":"57","author":"Law","year":"2016","journal-title":"J Nucl Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with 18 F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy.","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B92","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions.","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc Imaging."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s12350-019-01885-8","article-title":"F-sodium fluoride PET\/MRI myocardial imaging in patients with suspected cardiac amyloidosis.","volume":"28","author":"Abulizi","year":"2019","journal-title":"J Nucl Cardiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.jaccas.2020.05.062","article-title":"Abdominal fat biopsy for the diagnosis of cardiac amyloidosis.","volume":"2","author":"Aimo","year":"2020","journal-title":"JACC Case Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.humpath.2017.11.001","article-title":"Abdominal fat pad excisional biopsy for the diagnosis and typing of systemic amyloidosis.","volume":"72","author":"Garcia","year":"2018","journal-title":"Hum Pathol."},{"key":"B96","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American heart association.","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation."},{"key":"B97","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1161\/CIRCULATIONAHA.109.924167","article-title":"Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance.","volume":"122","author":"Yilmaz","year":"2010","journal-title":"Circulation."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.787618\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T03:28:18Z","timestamp":1648524498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.787618\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":97,"alternative-id":["10.3389\/fcvm.2022.787618"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.787618","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"article-number":"787618"}}